Glenmark expands diabetes portfolio with new Empagliflozin treatments

Table of Content


Glenmark Pharmaceuticals announced today the launch of Empagliflozin and its fixed-drug combinations in India under the brand names Glempa, Glempa-L, and Glempa-M.

The shares of Glenmark Pharmaceuticals Limited were trading today at ₹1,390.85 up by ₹9.35 or 0.67 per cent on the NSE today at 12.37 pm.

The SGLT2 inhibitor and its combinations are designed to improve glycemic control in adults with type 2 diabetes mellitus (T2DM) while reducing cardiovascular risks. Clinical trials have shown Empagliflozin reduces major cardiovascular events by 14 per cent in T2DM patients with high CV risks.

“Glenmark has a strong legacy of introducing innovative and accessible treatments for Cardiometabolic care in India,” said Alok Malik, President and Head of India Formulations Business. “The launch of Glempa range reinforces this commitment by providing a comprehensive and affordable solution.”

The Glempa product line includes three options: Glempa (Empagliflozin 10mg/25mg) as a standalone treatment, Glempa-L (Empagliflozin with Linagliptin) as a dual-action therapy, and Glempa-M (Empagliflozin with Metformin) for stronger glycemic control.

According to IQVIA data, the market for Empagliflozin and combinations in India was valued at 642 crore for the 12-month period ending January 2025.

This launch follows Glenmark’s 2024 introduction of Lirafit, a biosimilar for Liraglutide, marking the company’s entry into the injectable anti-diabetic market as part of its expanding cardiometabolic portfolio.





Source link

AIMPWA

mmkrishnandasu@gmail.com http://msmenews.sbs

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News

Trending News

Editor's Picks

Budget sows seeds of change for agriculture but gaps remain

The Economic Survey called agriculture the “sector of the future” and the FM echoed this sentiment in her budget speech, emphasizing garib, youth, annadata and nari. Despite this focus, key gaps remain. Firstly, there is a budget cut for agriculture ministry. Despite the rhetoric, the Ministry of Agriculture and Farmers’ Welfare (MOA) saw a ₹3,500...

Incentives for urban governance to improve quality of life

Finance minister Nirmala Sitharaman has followed a stable trajectory in all her Union Budgets since 2019. This year’s budget speech, though, was unusual in not mentioning allocations for specific Infrastructure sectors. The unsaid implication being – execute and implement existing projects in large sectors like highways and railways. Of the allocation to Infrastructure of an...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com